MGNX - Latest News
MacroGenics, Inc. (MGNX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $217.4M. Beta to the broader market is 1.21.
The article list below shows the most recent MGNX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MGNX Headlines
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
zacks.com - Oct 9, 2026
Here is how MacroGenics (MGNX) and C4 Therapeutics, Inc. (CCCC) have performed compared to their sector so far this year.
Stock Picks From Seeking Alpha's September 2026 New Analysts
seekingalpha.com - Oct 7, 2026
Seeking Alpha welcomed 38 new analysts in September 2026. This article showcases their top picks and investment strategies.
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com - Sep 9, 2026
ROCKVILLE, MD, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc.
MacroGenics: Inexpensive ADC/TCE Biotech With Multiple Catalysts Ahead
seekingalpha.com - Sep 9, 2026
Positive risk/reward with MacroGenics trading at a discount to its $327 million cash position or $5. 15/share.
Bank of America Corp DE Buys 564,094 Shares of MacroGenics, Inc. $MGNX
defenseworld.net - Aug 26, 2026
Bank of America Corp DE increased its stake in shares of MacroGenics, Inc. (NASDAQ: MGNX) by 30.
How News Affects MGNX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MGNX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked MGNX news questions
- What is the latest MGNX news headline?
- The most recent MGNX headline (Oct 9, 2026) is "Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MGNX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MGNX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MGNX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.